Johnson & Johnson gains FDA approval for Ottava robotic surgery system, challenging Intuitive Surgical's dominance
Johnson & Johnson has secured FDA marketing authorization for its Ottava robotic surgical system, positioning itself to compete in the soft-tissue robotic surgery market currently led by Intuitive Surgical. The device is designed for upper abdominal procedures.